These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6339126)

  • 21. Impaired monocyte function in primary biliary cirrhosis.
    Olmos JM; García JD; Jiménez A; de Castro S
    Allergol Immunopathol (Madr); 1988; 16(5):353-8. PubMed ID: 3228054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.
    Uehara M; Sato N
    Hepatology; 1994 Aug; 20(2):326-30. PubMed ID: 8045492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of medroxyprogesterone on the liver function and drug metabolism of patients with primary biliary cirrhosis and chronic active hepatitis.
    Sotaniemi EA; Hynnynen T; Ahlqvist J; Ahokas JT; Puoskari U; Pelkonen I
    J Med; 1978; 9(2):117-28. PubMed ID: 276564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease.
    Tagger A; Ribero ML; Larghi A; Donato F; Zuin M; Chiesa R; Benetti G; Ramella G; Borzio M; Podda M
    Am J Gastroenterol; 1999 Feb; 94(2):484-8. PubMed ID: 10022651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
    Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
    Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yeast opsonization and phagocytosis studied by a visual assay and measurement of neutrophil chemiluminescence.
    Vernon J; Kemp AS; Van Asperen PP; Worsdall P; Roy LP
    J Clin Lab Immunol; 1984 Jun; 14(2):93-7. PubMed ID: 6748051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etiologies of chronic liver diseases in Hong Kong.
    Fung KT; Fung J; Lai CL; Yuen MF
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):659-64. PubMed ID: 17625435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of C3b-binding in chronic liver diseases.
    Hautanen A; Salaspuro MP
    Scand J Gastroenterol; 1981; 16(4):505-12. PubMed ID: 7323688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Decreased serum osteocalcin level in non-alcoholic and alcoholic chronic liver diseases].
    Szalay F; Lakatos P; Németh J; Abonyi M; Büki B; Tarján G; Holló I
    Orv Hetil; 1991 Jun; 132(24):1301-5. PubMed ID: 1857606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.
    Yamamura M; Valdimarsson H
    Immunology; 1978 Apr; 34(4):689-94. PubMed ID: 363601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A defect of the alternative pathway of complement.
    Soothill JF; Harvey BA
    Clin Exp Immunol; 1977 Jan; 27(1):30-3. PubMed ID: 321158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.
    Teisberg P; Gjone E
    Clin Exp Immunol; 1973 Aug; 14(4):509-14. PubMed ID: 4201114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
    Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR
    Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.
    Fernandez-Cruz E; Escartin P; Bootello A; Kreisler M; Segovia de Arana JM
    Clin Exp Immunol; 1978 Mar; 31(3):436-42. PubMed ID: 657588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.
    Roberton DM; Dhanjal NK; Levinsky RJ; Mowbray JF; Turner MW
    Clin Exp Immunol; 1981 Jan; 43(1):208-14. PubMed ID: 7018758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.
    Paronetto F; Vernace S
    Clin Exp Immunol; 1975 Jan; 19(1):99-104. PubMed ID: 1204242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opsonization of serum-sensitive and serum-resistant Escherichia coli by rough mutant (Re) antisera.
    Crowley JP; Zinner SH; Peter G
    J Lab Clin Med; 1982 Feb; 99(2):197-205. PubMed ID: 7038008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.